HomeCDT • NASDAQ
Conduit Pharmaceuticals Inc
add
$1.01
0.00%
Pre-market:(1.13%)+0.011
$1.02
Closed: Mar 14, 9:03:45 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.41M | 1,158.37% |
Net income | -6.46M | -346.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.41M | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.00K | -98.24% |
Total assets | 2.99M | -75.10% |
Total liabilities | 12.11M | -7.54% |
Total equity | -9.12M | — |
Shares outstanding | 1.03M | — |
Price to book | -0.11 | — |
Return on assets | -429.58% | — |
Return on capital | 254.13% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.46M | -346.13% |
Cash from operations | -2.00M | -281.49% |
Cash from investing | 96.00K | 43.28% |
Cash from financing | 1.74M | -80.86% |
Net change in cash | -148.00K | -101.71% |
Free cash flow | 4.46M | — |
Previous close
$1.01
Year range
$0.98 - $392.00
Market cap
1.40M USD
Avg Volume
6.45M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2019
Headquarters
Website
Employees
7
